Actuate Therapeutics, Inc. Common stock ACTU
Set alert
0.34 USD -0.04 -9.68%
At close · Oct 30
0.34 0.00 -0.03%
After hours · Oct 30, 4:00 PM ET
0.33 Day range 0.385
0.33 52-week range 7.90
- YTD
- -94.52%
- 1 year
- -94.91%
- Open
- 0.38
- Prev close
- 0.371
- Mkt cap
- 18.43M
- Vol
- 489.47K
- Avg vol
- 413.88K
- EPS
- -0.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.33
- High
- 0.385
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.49
- Inst. own
- 53.05%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.35
- 200-d avg
- 8.07
- 1y target
- 0.00
Financial health
Altman Z-Score
-56.09 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -5.8×
FY 2022 5y median -5.5× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 16.2×
FY 2022 5y median 12.5× FY 2025
P/FCF -6.7×
FY 2022 5y median -6.9× FY 2025
EV/EBITDA -5.2×
FY 2022 5y median 229× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -14.9%
FY 2022 5y median -14.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -280.5%
FY 2022 5y median -208.2% FY 2025
ROIC -270.1%
FY 2022 5y median -197.6% FY 2025
ROA -158.4%
FY 2022 5y median -225.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income 10.6%
FY 2022 FY 2025
EPS (diluted) 67.5%
FY 2022 FY 2025
Free Cash Flow 12.1%
FY 2022 FY 2025
Financial Health
Current Ratio 2.4×
FY 2022 5y median 1.7× FY 2025
Quick Ratio 2.4×
FY 2022 5y median 1.7× FY 2025
Debt / Equity 0.1×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2022 5y median -5.1× FY 2025
Interest Coverage -1111×
FY 2022 5y median -842× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31